550 likes | 998 Views
!. RECEPTORS AND CELL - SURFACE MOLECULES OF MACROPHAGES. !. TLR4 + CD14. Scavenger receptor. Mannose receptor. MHCI. TLR – pattern recognition Rs. Fc RI (CD64). Ag + IgG complex. Fc RII (CD32). MHCII. M ϕ. Fc RIII (CD16). CR1 (CD35). LFA1 (CD11a/CD18). CR3 (CD11b/CD18). !.
E N D
! RECEPTORS AND CELL-SURFACE MOLECULES OF MACROPHAGES ! TLR4 + CD14 Scavenger receptor Mannose receptor MHCI TLR – pattern recognition Rs FcRI (CD64) Ag + IgG complex FcRII (CD32) MHCII Mϕ FcRIII (CD16) CR1 (CD35) LFA1 (CD11a/CD18) CR3 (CD11b/CD18)
! Anti-viral immune response Type I INTERFERONs vírus IFN és IFN !
! Anti-viral immune response Defense: Innate Immunity: – type I interferons(INFα, β) – NK cells Adaptive immunity B cells – antibody-mediated neutralization T cells --- cytotoxic T cells, cytokines
KINETICS OF VARIOUS ANTI-VIRAL MECHANISMS IFNα/β, IL-12 NK cells Cytotoxic T cells Antibody Complement level/activity VIRUS TITER days
IMMUNOLOGICAL MEMORY Inhabitants: 46 000 Area: 1 400 km2 • 1781: Measles epidemics in the Faroe islands • after the epidemics the island has remained measles free for 65 years • 1846: Another epidemics • Those, who were elder than 65 years and were sick in 1781 were not re-infected, but some elderly got sick • Life long protection against some viruses exists • Maintenance of memory does not require the sustained or intermitting presence of the virus
! ! THE TWO ARMS OF THE IMMUNE SYSTEM Differentiation between harmless and harmful impacts DETECTION OF STRESS AND DANGER SIGNALS INNATE IMMUNITY Differentiation between self and non-self structures Antigen-specific recognition ADAPTIVE IMMUNITY Neutralization and elimination of foreign and harmful structures EXECUTIVE FUNCTIONS COORDINATED AND REGULATED ACTIONS INNATE IMMUNITY • immediate reaction • not antigen-specific • no memory ADAPTIVE IMMUNITY • developes in several days • specific • has memory communication Humoral immunity Cellular immunity
! ! B cell memory: Quicker response Increase in the number of specific B cells The amounts of antibody are biger Higher affinity antibodies (‘more specific’) Isotype switch In case of T dependent B cell activation
! Antigen recognition by specific BCR induces clonal expansion and differentiation of the sepcific B cells. Activation of specific B cells 1. Clonalexpansion MEMORY B CELLS Plasma cells, antibody production 2.Differentiation
B cell memory is provided by: Memory B cells proliferation and differentiation to plasma cell upon re-activation or entry to the GC reaction again and Long-lived plasma cells Plasma cells generated during GCreaction migrate to bone marrow and survive for years, producing antibodyMuch of circulating IgG is produced by long-lived plasma cells, provides initial protection
! Repeated immunization primary response against B antigen days
B B B B B B B B B B IMMUNOLOGICAL MEMORY – B CELLS SUMMARY Germinal Center reaction • B cell proliferation • Somatic hypermutation • Affinity maturation Memory B cells • Perviously activated • Passed through affinity maturation • Present in the circulation • proliferation and differentiation to plasma cell upon re-activation or entry to the GC reaction again Plasma cells Provides serological memory by pre-existing neutralizing Abs to pathogens and/or toxins B B FDC B FDC B T B plasma cell B – T cellcollaboration T B
T-CELL MEMORY Central memory cells Effector memory cells
! ! T cell memory: Quicker response Increase in the number of responding cells
DEVELOPMENT OF CELLULAR MEMORY Negative regulation of the immune system AICD Activation Induced Cell Death DIFFERENTIATION Naive lymphocytes Memory Az antigen-specific cell number Secondary effector T cells Primary effector cells EXPANSION AICD MEMORY Days
Central memory T PERIPHERAL LYMPHOID ORGANS Effector T Citokines/cytotoxicity Naive T Effector T AICD Citokines/Cytotoxicity Effector memory T PERIPHERAL TISSUES Skin dermis, gut lamina propria, alveolar space Tissue-specific migration Effector T Cytokines/cytotoxicity ANTIGEN/SITE OF INFECTION
IMMUNOLOGICAL MEMORY MEDIATED BY T LYMPHOCYTES Naive T cell Effector T cell 2X107 cytokine production cytotoxicity Central Memory T cell Effector T cell Maintained by cytokines: IL-7, IL-15 • Previously activated, partially differentiated cell type • Circulating CCR7+ cells in blood, lymphoid tissues • High proliferation rate induced by activation signals • Rapid differentiation to effector cells 2X105 Effector Memory T cell Effector T cell • Previously activated, partially differentiated cell type • Closest to the effector state • Circulating CCR7- cells in blood and tissues • Slow proliferation, rapid effector functions
Functional differences between lymphoid tcm cells and tissue-resident TEM cells Proliferation Cytotoxicity cytotoxicity killing Woodland DL & Kohlmeier JR 2009 Nat Rev 9:153
AGE THYMUS PERIPHERY M E M O R Y N A I V E IMMUNOLOGICAL EXPERIENCE
Active: generates memory response Passive: ensure the protection by premade antibodies (the adaptive immune system of the person is not activated)
! !
mouse monoclonal antibodies immunization humanized mouse monoclonal antibodies immunization Human immunoglobulin transgenic mouse human monoclonal antibodies ENDANGERED SUBJECT PASSZÍV IMMUNIZÁLÁS PROTECTED SUBJECT serum antibody This is a case of PASSIVE IMMUNIZATION Immune system is not activated prompt effect temporary protection/effect Immunoglobulin degradation
Active and passive immunization activepassive protection slowimmediate (2 weeks) Time-span longshort (years) ! ! passive protection active injection time
! Anti-viral immune response Defense: Innate Immunity: – type I interferons(INFα, β) – NK cells Adaptive immunity B cells – antibody-mediated neutralization T cells --- cytotoxic T cells, cytokines
Pathological consequences of placental transport of IgG (hemolytic disease of the newborn) anti-Rh IgM Passive anti-D IgG
Immunization Active Passive Host itself produce preformed antibodies antibodies and cells are imported to the host biotic biotic artificial artificial
Immunitás Természetes Aktív: betegség, immunizálódás (sorozatos találkozás az adott kórokozóval) Passzív-in utero, placentán át, maternális (anyai IgG, folyamatos, homológ) - születés után, colostrális, anyatej útján IgG, IgA